The novel approach of tirzepatide peptide represents a significant development in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – leading https://tirzepatidepeptide747460.izrablog.com/42371510/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment